Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
D000925:Anticoagulants / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D001921:Brain / Q000098:blood supply; D002994:Clofibrate / Q000494:pharmacology; D003911:Dextrans / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D006801:Humans; D007511:Ischemia / Q000188:drug therapy; D007674:Kidney Diseases / Q000188:drug therapy; D009203:Myocardial Infarction / Q000188:drug therapy; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D012702:Serotonin Antagonists; D013442:Sulfinpyrazone / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology; D013927:Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D003911:Dextrans; D012702:Serotonin Antagonists; D013566:Sympathomimetics; D004176:Dipyridamole; D002994:Clofibrate; D001241:Aspirin; D013442:Sulfinpyrazone